Latest News

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – August 14, 2025

August 15th 2025

Review top news and interview highlights from the week ending August 15, 2025.

EMA's CHMP Gives Ocugen the Green Light to Submit MAA for OCU410ST Based on GARDian3 Trial
EMA's CHMP Gives Ocugen the Green Light to Submit MAA for OCU410ST Based on GARDian3 Trial

August 14th 2025

Around the Helix: Cell and Gene Therapy Company Updates – August 13, 2025
Around the Helix: Cell and Gene Therapy Company Updates – August 13, 2025

August 13th 2025

Omotayo Fasan, MRCP, DTM&H, MBBS, the head of the clinical development program at Galapagos
Galapagos Snags FDA RMAT Designation for R/R Mantle Cell Lymphoma CAR T-Cell Therapy

August 13th 2025

Video Interviews

Conference Coverage

View All
Rajeev Sivasankaran, PhD, vice president of neuroscience at Voyager Therapeutics
Voyager’s Single-Dose AAV Strategy for Silencing Tau for Alzheimer Disease

August 12th 2025

Alzheimer Disease Gene Therapy Provides Restoration of Entorhinal Cortex FDG-PET Activity in Phase 1 Trial
Alzheimer Disease Gene Therapy Provides Restoration of Entorhinal Cortex FDG-PET Activity in Phase 1 Trial

August 10th 2025

Rajeev Sivasankaran, PhD, vice president of neuroscience at Voyager Therapeutics
Rajeev Sivasankaran, PhD, on Voyager’s Single-Dose AAV Strategy for Silencing Tau for Alzheimer Disease

August 6th 2025

Sven Moller-Tank, PhD, a senior director at Regeneron
Regeneron’s Future Plans for Its AAV Targeting Approach

July 28th 2025

All News

© 2025 MJH Life Sciences

All rights reserved.